Author: Dermaut B.
Publisher: Oxford University Press
ISSN: 1460-2156
Source: Brain, Vol.124, Iss.12, 2001-12, pp. : 2383-2392
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The dense-cored plaques are considered the pathogenic type of amyloid deposition in Alzheimer's disease brains because of their predominant association with dystrophic neurites. Nevertheless, in >90% of cases of Alzheimer's disease amyloid is also deposited in cerebral blood vessel walls (congophilic amyloid angiopathy; CAA) but its role in Alzheimer's disease pathogenesis remains enigmatic. Here, we report a family (family GB) in which early-onset Alzheimer's disease was caused by a novel presenilin 1 mutation (L282V). This was unusually severe CAA reminiscent of the Flemish amyloid precursor protein (A692G) mutation we reported previously, which causes Alzheimer's disease and/or cerebral haemorrhages. In family GB, however, the disease presented as typical progressive Alzheimer's disease in the absence of strokes or stroke-like episodes. Similarly, neuroimaging studies and neuropathological examination favoured a degenerative over a vascular dementia. Interestingly, an immunohistochemical study revealed that, similar to causing dense-cored amyloid plaques, CAA also appeared capable of instigating a strong local dystrophic and inflammatory reaction. This was suggested by the observed neuronal loss, the presence of tau- and ubiquitin-positive neurites, micro- and astrogliosis, and complement activation. Together, these data suggest that, like the dense-cored neuritic plaques, CAA might represent a pathogenic lesion that contributes significantly to the progressive neurodegeneration that occurs in Alzheimer's disease.
Related content
Cerebral Amyloid Angiopathy in Alzheimer's Disease and Related Disorders.
By Lammie A.
Brain, Vol. 124, Iss. 5, 2001-05 ,pp. :
Alzheimer's disease due to an intronic presenilin-1 ( PSEN1 intron 4) mutation
By Cipolotti L.
Brain, Vol. 123, Iss. 5, 2000-05 ,pp. :
LRP1 and cerebral amyloid angiopathy
By Kanekiyo Takahisa Bu Guojun
Future Neurology, Vol. 4, Iss. 1, 2009-01 ,pp. :